What is the investment value of Beijing Tongrentang Co., Ltd.? The main business of Beijing Tongrentang Co., Ltd. is the research and development, production and sales of traditional Chinese medicine; the company’s main products are Angong Niuhuang Pills, Tongren Niuhuang Qingxin Pills, and Tongren Dahuoluo Pills; Tongrentang is a well-known Chinese time-honored brand in the traditional Chinese medicine industry; Tongrentang's top ten flagship products represented by Angong Niuhuang Pills, Tongren Niuhuang Qingxin Pills, and Tongren Dahuoluo Pills, as well as many classic drugs, are household names and are well-known at home and abroad. They are widely used in the treatment of clinical patients. Enjoying a high reputation, the company's business covers 20 countries and regions, with 71 retail terminals, forming an international network layout of "based on Hong Kong, China, deeply involved in the mainstream, and facing the world". The "Tongrentang" trademark used by the company belongs to the controlling shareholder Tongrentang Group. The trademark was recognized as a well-known trademark by the Trademark Office of the State Administration for Industry and Commerce in 1989.
1. Enterprise analysis
1. Basic situation
The full name of Tongrentang (600085) is Beijing Tongrentang Co., Ltd., which was listed on the Main Board A of the Shanghai Stock Exchange on June 25, 1997 The company is listed on the stock market and is located at No. 33 Tiangui Street, Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District, Beijing; Grant Thornton Accounting Firm (Special General Partnership) issued a standard unqualified audit report for Tong Ren Tang. Main business: research and development, production and sales of traditional Chinese medicine.
2. Market scale
In 2019, the transaction volume of my country's traditional Chinese medicinal materials market reached 165.3 billion yuan; in 2020, the transaction volume of China's traditional Chinese medicinal materials market was nearly 191.9 billion yuan. The traditional Chinese medicine industry has a large market size and is currently in a growth stage. 3. Development trends of the traditional Chinese medicine industry
(1) The supervision of traditional Chinese medicine prepared pieces has been strengthened and the quality of prepared preparations has been improved
In 2020, the National Administration released the 2020 "Special Rectification Work Plan for Traditional Chinese Medicine Prepared Pieces" nationwide. Food regulatory authorities in various places have begun to conduct random inspections of traditional Chinese medicine pieces. With the launch of large-scale, full-coverage inspections of traditional Chinese medicine pieces, as well as the upgrade of illegal penalties and the improvement of the traceability system, higher requirements have been put forward for the entire chain of the traditional Chinese medicine industry. In 2021 The quality of traditional Chinese medicine pieces is expected to be fundamentally improved, the overall trend will be growth, and the market size will be further expanded.
(2) Traditional Chinese medicine formula granules are standardized and the market develops steadily
Traditional Chinese medicine formula granules can give full play to the advantages of traditional Chinese medicine decoctions in individualized diagnosis and treatment, and can take into account modern Chinese medicine. With the characteristics of easy portability, simple and fast use, its market has been expanding in recent years, and its types are also increasing day by day. On December 28, 2020, the "General Specifications for the Production of Traditional Chinese Medicine Formula Granules" was officially implemented. The "Specifications" provide operable group standards for traditional Chinese medicine formula granule manufacturers. While improving the industry's production capacity, it will also greatly improve The regulatory efficiency of regulatory agencies has filled the gaps in the domestic production and supervision of traditional Chinese medicine formula granules. In 2021, policies will become more standardized, and my country's formula granule market has huge room for improvement. Under the premise of technological innovation and equipment upgrading, it will help the stable development of my country's formula granule market.
(3) The state promotes the “conversion” of folk Chinese medicine practitioners
Folk Chinese medicine practitioners are a special and indispensable group of Chinese medicine practitioners. Moreover, folk Chinese medicine is often cultivated through teacher-teacher, family inheritance, etc., and it is difficult to evaluate its true level through the existing physician qualification examination. In 2020, the State Council officially abolished the "Regulations of the People's Republic of China and the State on Traditional Chinese Medicine" to allow private Chinese medicine practitioners to "confirm", opening up a new way to obtain Chinese medicine physician qualifications through practical skills and effect assessment. In 2021, it will be more convenient for private Chinese medicine practitioners to open TCM clinics, effectively improving the grassroots TCM service capabilities, strengthening the grassroots TCM service team, and promoting the orderly development of the TCM industry.